Phio Pharmaceuticals Corp.: which funds bought and sold
Institutions that bought and sold Phio Pharmaceuticals shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 10 institutions that filed 13F reports for both quarters added to or opened positions in Phio Pharmaceuticals, and 12 cut or closed them. Together they sold a net 21K shares, −3.2% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 48K shares (+148.2%); index fund managers were net sellers of 14K shares (−4.9%). 4 opened a new position and 4 sold out entirely.
Bought, Q2 2026 10 institutions, 4 of them new holders Sold, Q2 2026 12 institutions, 4 of them sold out
Net change, all compared −21K shares (−3.2%)
Net change, active managers +48K shares (+148.2%), 2 bought, 1 sold
Buyers versus sellers
10 bought 6 12 sold
Active managers and hedge funds 2 bought · 1 sold · +48K
Index fund managers 2 bought · 1 sold · −14K
Other institutions 6 bought · 10 sold · −55K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Nomura Asset Management International Inc. | +50K New position | 50K | $51,000 |
| Citadel Advisors LLC Hedge fund | +47K New position | 47K | $48,329 |
| Vanguard Capital Management LLC Index funds | +14K +18.0% | 94K | $96,619 |
| Bridgeway Capital Management, LLC Active manager | +12K New position | 12K | $12,300 |
| Citigroup Inc | +11K +1032.2% | 12K | $11,895 |
| Northern Trust Corp Index funds | +4,010 +16.9% | 28K | $28,462 |
| Cetera Investment Advisers | +2,500 +5.6% | 48K | $48,688 |
| Barclays PLC | +231 New position | 231 | $237 |
| Sbi Securities Co., Ltd. | +23 +1.9% | 1,247 | $1,278 |
| Caitong International Asset Management Co., Ltd | +3 +100.0% | 6 | $6 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +47K New position | 47K | $48,329 |
| Bridgeway Capital Management, LLC Active manager | +12K New position | 12K | $12,300 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Geode Capital Management, LLC Index funds | −33K −22.2% | 115K | $117,437 |
| Scientech Research LLC | −30K Sold out | 0 | — |
| UBS Group AG | −22K −80.0% | 5,387 | $5,522 |
| HRT Financial LP | −22K −62.0% | 13K | $13,000 |
| Gsa Capital Partners LLP | −20K Sold out | 0 | — |
| Two Sigma Securities, LLC | −15K Sold out | 0 | — |
| Two Sigma Investments, LP Hedge fund | −11K −33.8% | 22K | $22,039 |
| Xtx Topco Ltd | −6,393 −25.7% | 18K | $18,937 |
| Jane Street Group, LLC | −1,434 −1.2% | 118K | $120,699 |
| Tower Research Capital LLC (TRC) | −1,414 −18.6% | 6,206 | $6,361 |
| Lanark Financial, Inc. | −1,074 Sold out | 0 | — |
| Spire Wealth Management | −10 −0.5% | 1,990 | $2,050 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Two Sigma Investments, LP Hedge fund | −11K −33.8% | 22K | $22,039 |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Nomura Asset Management International Inc. | 50K | $51,000 |
| Citadel Advisors LLCHedge fund | 47K | $48,329 |
| Bridgeway Capital Management, LLCActive manager | 12K | $12,300 |
| Barclays PLC | 231 | $237 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Scientech Research LLC | 30K | $36,639 |
| Gsa Capital Partners LLP | 20K | $24,000 |
| Two Sigma Securities, LLC | 15K | $18,573 |
| Lanark Financial, Inc. | 1,074 | $1,310 |
Who holds the shares
- Institutions reporting
- 24
- Ten largest holders
- 89.2% of 13F-reported shares
- Index fund managers
- 42.5% of 13F-reported shares
- Active managers and hedge funds
- 12.5% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 2 | 1 | 2 | 0 | +48K | +148.2% |
| Index fund managers | 2 | 1 | 0 | 0 | −14K | −4.9% |
| Other institutions | 6 | 10 | 2 | 4 | −55K | −15.9% |
← Back to Phio Pharmaceuticals Corp. · Insiders · Politicians